Perrigo InvestorRoom Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules Wed, 27 Sep 2017 08:30:00 -0400 Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets Thu, 21 Sep 2017 09:29:00 -0400 Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel Mon, 18 Sep 2017 08:45:00 -0400 Perrigo Company To Present At Upcoming Investor Conferences Wed, 30 Aug 2017 09:01:00 -0400 Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules Mon, 21 Aug 2017 09:00:00 -0400